Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio Target Price

Analysts' average 12-month price target for Nuvation Bio is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.81

Average Target Price

$20.00

193.7% upside

3 analysts in the last 4 months

High: $21 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	RBC CapitalLeonid Timashev	$20	193.7% upside
2026-07-27	H.C. Wainwright	$21	208.4% upside
2026-07-07	RBC Capital	$19	179% upside
2026-01-27	Truist Financial	$13	90.9% upside
2026-01-21	RBC CapitalLeonid Timashev	$12	76.2% upside
2026-01-12	H.C. Wainwright	$17	149.6% upside
2026-01-07	UBSMichael Yee	$10	46.8% upside
2025-12-11	H.C. Wainwright	$18	164.3% upside
2025-12-01	H.C. WainwrightRobert Burns	$10	46.8% upside
2025-11-24	Truist Financial	$11	61.5% upside
2025-11-20	JMP Securities	$10	46.8% upside
2025-11-04	JMP Securities	$8	17.5% upside
2025-04-23	JMP SecuritiesSilvan Tuerkcan	$6	11.9% downside
2024-09-16	H.C. WainwrightRobert Burns	$7	2.8% upside
2024-04-17	RBC CapitalKennen MacKay	$5	26.6% downside
2024-03-28	H.C. WainwrightRobert Burns	$8	17.5% upside
2024-03-27	JefferiesMichael Yee	$10	46.8% upside
2024-03-26	BTIGKaveri Pohlman	$5	26.6% downside
2023-01-06	Jefferies	$2	70.6% downside
2022-05-04	H.C. Wainwright	$14	105.6% upside

Nuvation Bio (NUVB) FAQ

Nuvation Bio posts a target price of $20. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $20 for NUVB means covering analysts, on average, see the stock 193.7% upside of $6.81 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for NUVB's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Nuvation Bio's other metric pages and overview cover the third.

Judging Nuvation Bio against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $20 here, then scan peer and history charts to see if the gap is persistent.